New Zealand proposed privatisation of hospital labs could hit key tests, surveillance & public access
This article was originally published in Clinica
New Zealand's Otago and Southland district health boards (DHBs) have made a joint recommendation to government that hospital laboratory services be contracted out to the private sector. Healthcare product manufacturers and others within the health industry are concerned that the move would threaten the number and quality of laboratory services available to the public.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.